Acciones InDex Pharmaceuticals Holding AB (publ) Nasdaq Stockholm
Acciones
SE0008966295
Farmacéuticos
Ventas 2024 * | - | Ventas 2025 * | - | Capitalización | 206 M 2229,5 M 192 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | -259 M -2801,07 M -241 M | Resultado Neto 2025 * | -221 M -2390,1 M -205 M | VE / Ventas 2024 * | - |
Deuda neta 2024 * | 86,32 M 934 M 80,22 M | Deuda neta 2025 * | 306 M 3307,75 M 284 M | VE / Ventas 2025 * | - |
P/E ratio 2024 * |
-0,79
x | P/E ratio 2025 * |
-0,94
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 62,47 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 01/01/23 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 01/05/17 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 01/01/16 |
Director/Board Member | 68 | 01/01/11 | |
Chairman | 72 | 01/01/11 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,08 % | 662 mil M | |
+21,85 % | 546 mil M | |
-4,77 % | 359 mil M | |
+16,97 % | 323 mil M | |
+5,69 % | 290 mil M | |
+13,68 % | 234 mil M | |
+3,65 % | 198 mil M | |
-11,12 % | 194 mil M | |
+8,08 % | 167 mil M |